Log in

Indivior Share Forecast, Price & News

GBX 110.11
+5.81 (+5.57 %)
(As of 10/30/2020 05:36 PM ET)
Today's Range
Now: GBX 110.11
50-Day Range
MA: GBX 111.41
52-Week Range
Now: GBX 110.11
Volume10.43 million shs
Average Volume2.45 million shs
Market Capitalization£807.66 million
P/E RatioN/A
Dividend YieldN/A
Indivior PLC, together with its subsidiaries, develops, manufactures, and sells buprenorphine-based prescription drugs for the treatment of opioid dependence. The company's product pipeline focuses on treating opioid use disorder, alcohol use disorder, opiate overdose, and schizophrenia. It markets and promotes SUBLOCADE injection for subcutaneous use; and SUBOXONE sublingual film, SUBOXONE sublingual tablet, and SUBUTEX sublingual tablet, as well as sells legacy analgesic products that include Temgesic, Burpex, and Buprenex. The company operates in approximately 40 countries worldwide. Indivior PLC was incorporated in 2014 and is headquartered in North Chesterfield, Virginia.
Read More
Indivior logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.3Community Rank: 3.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.33 out of 5 stars

Industry, Sector and Symbol

Industry Drugs - Generic



Sales & Book Value

Annual Sales£634 million
Cash FlowGBX 127.60 per share
Book ValueGBX 7.90 per share



Market Cap£807.66 million
Next Earnings DateN/A
OptionableNot Optionable
GBX 110.11
+5.81 (+5.57 %)
(As of 10/30/2020 05:36 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive INDV News and Ratings via Email

Sign-up to receive the latest news and ratings for INDV and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Indivior (LON:INDV) Frequently Asked Questions

How has Indivior's stock been impacted by COVID-19 (Coronavirus)?

Indivior's stock was trading at GBX 46.21 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, INDV shares have increased by 138.3% and is now trading at GBX 110.11.
View which stocks have been most impacted by COVID-19

Do Wall Street analysts recommend investors buy shares of Indivior?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Indivior in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Indivior

What price target have analysts set for INDV?

2 brokers have issued 12 month price targets for Indivior's stock. Their forecasts range from GBX 85 to GBX 200. On average, they anticipate Indivior's stock price to reach GBX 142.50 in the next twelve months. This suggests a possible upside of 29.4% from the stock's current price.
View analysts' price targets for Indivior

Who are some of Indivior's key competitors?

What other stocks do shareholders of Indivior own?

Who are Indivior's key executives?

Indivior's management team includes the following people:
  • Mr. Shaun Thaxter, CEO & Exec. Director
  • Mr. Mark Crossley, CFO & Exec. Director
  • Dr. Christian Heidbreder, Chief Scientific Officer
  • Mr. Ingo Elfering, Chief Information & Innovation Officer
  • Mr. Jason Thompson, VP of Investor Relations

What is Indivior's stock symbol?

Indivior trades on the London Stock Exchange (LON) under the ticker symbol "INDV."

How do I buy shares of Indivior?

Shares of INDV and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Indivior's stock price today?

One share of INDV stock can currently be purchased for approximately GBX 110.11.

How big of a company is Indivior?

Indivior has a market capitalization of £807.66 million and generates £634 million in revenue each year. Indivior employs 915 workers across the globe.

What is Indivior's official website?

The official website for Indivior is indivior.com.

How can I contact Indivior?

Indivior's mailing address is 103-105 Bath Road, SLOUGH, SL1 3UH, United Kingdom. The specialty pharmaceutical company can be reached via phone at +44-1753-217800.

This page was last updated on 10/31/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.